Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S K Swan

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Drugs|September 1, 1994
Diuretic strategies in patients with renal failureS K Swan
Contributions to Nephrology|January 1, 1997
Role of lipids in chronic renal allograft rejectionS K Swan
Seminars in Nephrology|January 1, 1997
Aminoglycoside nephrotoxicityS K Swan
Clinical Chemistry|June 1, 1997
The search continues--an ideal marker of GFRS K Swan
The Western Journal of Medicine|June 1, 1992
Drug dosing guidelines in patients with renal failureS K Swan, W M Bennett
Pharmacotherapy|March 24, 2000
The pharmacokinetics and pharmacodynamics of argatroban: effects of age, gender, and hepatic or renal dysfunctionS K Swan, M J Hursting
Mineral and Electrolyte Metabolism|January 1, 1991
Role of the sodium ion in acute renal failureS K Swan, W M Bennett
Annals of Internal Medicine|July 15, 1989
Oral acyclovir and neurotoxicityS K Swan, W M Bennett
Seminars in Dialysis|March 31, 2000
The generation of non-dextran intravenous iron: is iron dextran obsolete?M J Lewis, S K Swan
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 6, 2001
Cyclooxygenase-2 and atherosclerosis: friend or foe?Z A Massy, S K Swan
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Drugs|September 1, 1994
Diuretic strategies in patients with renal failureS K Swan
Contributions to Nephrology|January 1, 1997
Role of lipids in chronic renal allograft rejectionS K Swan
Seminars in Nephrology|January 1, 1997
Aminoglycoside nephrotoxicityS K Swan
Clinical Chemistry|June 1, 1997
The search continues--an ideal marker of GFRS K Swan
The Western Journal of Medicine|June 1, 1992
Drug dosing guidelines in patients with renal failureS K Swan, W M Bennett
Pharmacotherapy|March 24, 2000
The pharmacokinetics and pharmacodynamics of argatroban: effects of age, gender, and hepatic or renal dysfunctionS K Swan, M J Hursting
Mineral and Electrolyte Metabolism|January 1, 1991
Role of the sodium ion in acute renal failureS K Swan, W M Bennett
Annals of Internal Medicine|July 15, 1989
Oral acyclovir and neurotoxicityS K Swan, W M Bennett
Seminars in Dialysis|March 31, 2000
The generation of non-dextran intravenous iron: is iron dextran obsolete?M J Lewis, S K Swan
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 6, 2001
Cyclooxygenase-2 and atherosclerosis: friend or foe?Z A Massy, S K Swan
Pageof 5